The Effects of Two Different Treatment Protocols on Shoulder Function, Quality of Life, and Ultrasound Parameters in Patients With Frozen Shoulder
Frozen Shoulder, Shoulder Capsulitis, Shoulder Pain
About this trial
This is an interventional treatment trial for Frozen Shoulder focused on measuring hydrodilatation, hydrodistension, ultrasound
Eligibility Criteria
Inclusion Criteria: Patients who fulfill the diagnostic criteria for frozen shoulder Agree to participate in the study Having the opportunity to follow up for at least 3 months Exclusion Criteria: Refusing to participate in the study History of shoulder injection in the last 3 months Having diabetes mellitus Presence of comorbidities that contraindicate injection therapy, such as bleeding diathesis Known history of allergy or anaphylaxis to drugs used in treatment
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Ultrasound Guided Hydrodilatation with corticosteroid injection
Blind intra-articular corticosteroid injection
15 ml intra-articular injection to shoulder via anterior approach under ultrasound guidance Drugs: betamethasone dipropionate/ betamethasone sodium phosphate(diprospan) (5 mg+2mg/ml) (1 ml) prilocaine hydrochloride %2 (4 ml) Sodium chloride %0,9 (10 ml)
5 ml intra-articular blind injection to shoulder via posterior approach Drugs: betamethasone dipropionate/ betamethasone sodium phosphate(diprospan) (5 mg+2mg/ml) (1 ml) prilocaine hydrochloride %2 (4 ml)